Fairmount Healthcare Co-Invest III L.P. insider trades: Oruka Therapeutics (ORKA) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Fairmount Healthcare Co-Invest III L.P. reports to the SEC
Open-market buys and sales
1 trade reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jul 1, 2026 | ORKA | ↓ Sell | 3,553,410 | $84.43 | $300.0M | By Fairmount Healthcare Fund II L.P. | Jul 1, 2026 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ORKA insiders
Open-market trades in the last 12 months
About Fairmount Healthcare Co-Invest III L.P.'s insider trades
Fairmount Healthcare Co-Invest III L.P. is a director at Oruka Therapeutics (ORKA). Since Jul 1, 2026, it has reported no open-market purchases and 1 sale worth $300.0M on SEC Form 4. In the last 12 months: 1 sale ($300.0M).
Its filings also include grants and awards (3 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ORKA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.